Accounting & TaxationLarry Walther, Ph.D., CPA, CMADavid George Vequist IV, Ph.D.
Business FundamentalsRalph W Flanary, MBA, CFEThomas Coe
Business StrategyJames Richardson, Ph.D.
Career Readiness - Exploring Your PotentialBob Cohen, MBA
EconomicsBrian Kench, Ph.D.Derek Abrams
EntrepreneurshipCraig A. Turner, Ph.D.
FinanceDelvin D. Hawley, Ph.D.
Information TechnologyAngelina I. T. Kiser, Ph.D.
International BusinessDuane Helleloid, Ph.D.
Operations ManagementJames J. Stewart, DScPedro M. Reyes, Ph.D.
Org Behavior & HRKatherine Campbell, Ph.D.
Recent Reviews All Reviews
Douglas Wigdor, a life-long Republican, has risen to prominence as an anti-discrimination lawyer based on his multiple cases against Fox News.
A minor industry has developed in visas through the EB-5 program. The EB-5 program lets immigrants obtain residency visas in exchange for investing at least $500,000 in distressed areas in the United States.
AbbVie Inc., the maker of Humira, a biologic treatment for inflammatory diseases, uses a patent thicket strategy to maintain a monopoly over the drug. AbbVie has over 100 patents on Humira, covering manufacturing processes, drug formulation, methods of treatment, and other aspects of the drug.
Lax regulations in the Houston area aggravated the devastation of Hurricane Harvey.
Johnson & Johnson, the world’s largest health care provider, was recently handed a $417 judgment for its failure to warn customers of the link between talc in baby powder and ovarian cancer.